Rituximab as First-line Therapy for Severe Pemphigus: A Case Series and Review of Current Literature
Malaysian Journal of Dermatology
;
: 70-76, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-961862
ABSTRACT
Summary@#Pemphigus refers to a group of life-threatening, autoimmune blistering disease that presents as blisters and erosions involving the skin and mucosa. Systemic corticosteroids and rituximab have been recommended as mainstay therapy for pemphigus vulgaris and pemphigus foliaceus. Herein, we report three cases of pemphigus vulgaris and a case of pemphigus foliaceus treated with rituximab as first-line therapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pénfigo
/
Rituximab
Idioma:
Inglés
Revista:
Malaysian Journal of Dermatology
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS